AEBP1 and metabolic dysfunction-associated steatohepatitis: Finally, miR-372-3p and miR-373-3p, which may function to downregulate AEBP1 and are known to regulate canonical WNT signaling [45, 46], are reduced in NASH patients with advanced fibrosis.